RxDoctor Payments Data

Kayla Smith, APRN

Family · Bowling Green, KYNPI 1831721018

Payments from drug & device makers

$9,609in general payments, 2019–2025

Across 423 payments — averaging $22.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$956
  • Novartis$798
  • Daiichi Sankyo Inc.$609
  • Merck$537
  • Johnson & Johnson$466
  • AbbVie$444
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$9,24596%
  • Education$3644%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)26$956
Novartis42$798
Daiichi Sankyo Inc.28$609
Merck29$537
Johnson & Johnson19$466
AbbVie17$444
Pfizer22$358
Gilead11$300
Bristol Myers Squibb15$294
Seagen Inc.10$284
Regeneron Healthcare Solutions, Inc.11$282
Incyte Corporation15$239
AVEO Pharmaceuticals, Inc.6$224
Genentech USA, Inc.10$218
Angiodynamics, Inc.3$216
Iovance Biotherapeutics, Inc.2$214
Eisai Inc.8$167
E.r. Squibb & Sons, L.L.C.8$157
Beone Medicines USA, Inc.4$143
Lilly USA, LLC7$130
Takeda Pharmaceuticals U.S.A., Inc.6$130
Genmab U.S., Inc.5$119
Bayer7$111
Amgen6$110
Sanofi4$97
Astellas Pharma US Inc5$93
Coherus Oncology, Inc.5$91
Tersera Therapeutics LLC3$84
ADC Therapeutics America, Inc.5$82
EMD Serono, Inc.2$79
Pharmacyclics LLC, An Abbvie Company5$76
Exelixis Inc.3$76
G1 Therapeutics, Inc.4$75
Geron Corporation2$74
Beigene USA, Inc.4$71
Karyopharm Therapeutics Inc.4$69
Array Biopharma Inc6$67
Pharmaessentia USA Corporation3$66
Taiho Oncology, Inc.3$64
Blueprint Medicines Corporation3$60
Morphosys, US Inc.3$57
Pharmacosmos Therapeutics Inc.3$54
Sun Pharmaceutical Industries Inc.3$52
Boehringer Ingelheim2$51
Ipsen Biopharmaceuticals, Inc3$50
Celltrion USA Inc.2$50
Stemline Therapeutics Inc.2$47
Sobi, Inc2$43
Mirati Therapeutics, Inc.2$41
Azurity Pharmaceuticals, Inc.1$38
Rigel Pharmaceuticals, Inc.2$37
Kyowa Kirin, Inc.2$36
Puma Biotechnology, Inc.2$34
Myovant Sciences Inc.2$31
Novocure Inc.1$24
Progenics Pharmaceuticals, Inc.1$24
CSL Behring1$21
Accord Healthcare, Inc.1$21
Aadi Bioscience, Inc.1$20
TG Therapeutics, Inc.1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,609 in reported general payments places this provider in the 95th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$10,723
Medicare patients
96
Services billed
139

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Bowling Green

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →